PharmaVentures appoints senior director

Paul Phull will develop corporate advisory business

PharmaVentures, based in Oxford, UK, has hired Paul Phull as senior director to develop its corporate advisory business.

PharmaVentures is an international corporate advisory firm supporting its clients’ growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisers, investment companies and government bodies.

Phull joins the company from Sinclair Pharma, a specialist pharmaceutical company in the UK, where he was responsible for the development of the international business. He has significant deal making and corporate transaction experience with a broad range of companies in Europe, US, Japan, India and Asia in a number of therapeutic areas.

You may also like

Research & Development
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the company to accelerate its Parkinson’s disease pipeline
Manufacturing
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Finance
Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

The deal adds StatLab's 50-year histology workflow portfolio to Leica Biosystems' computational pathology platform, supporting laboratory standardisation for AI-driven cancer diagnostics at scale
Finance
Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

The private equity firm has agreed to acquire Germany's Primed Group, backing investment in medical consumables manufacturing, sterilisation services and international growth
Distribution
Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Agreement strengthens Brenntag’s position in biopharma and API markets in Europe
Manufacturing
Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

The deal pairs Nottingham's OSD development and clinical supply expertise with Codis' commercial-scale Haverhill facility, offering pharma partners an integrated ASD development-to-manufacture pathway within a single quality system
Finance
Novartis to acquire ADC biotech Myricx Bio for $1.5bn

Novartis to acquire ADC biotech Myricx Bio for $1.5bn

The pharma giant will add the biotech's novel NMTi payload platform to its roster, which may have potential in multiple solid tumour settings and overcome issues that have troubled ADC therapies, such as payload resistance and tolerability
Subscribe now